These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32447321)

  • 1. Integrated case-control and somatic-germline interaction analyses of soft-tissue sarcoma.
    Hu F; Yu Y; Chen JS; Hu H; Scheet P; Huff CD
    J Med Genet; 2021 Mar; 58(3):145-153. PubMed ID: 32447321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated case-control and somatic-germline interaction analyses of melanoma susceptibility genes.
    Yu Y; Hu H; Chen JS; Hu F; Fowler J; Scheet P; Zhao H; Huff CD
    Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt B):2247-2254. PubMed ID: 29317335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
    Couch FJ; Shimelis H; Hu C; Hart SN; Polley EC; Na J; Hallberg E; Moore R; Thomas A; Lilyquist J; Feng B; McFarland R; Pesaran T; Huether R; LaDuca H; Chao EC; Goldgar DE; Dolinsky JS
    JAMA Oncol; 2017 Sep; 3(9):1190-1196. PubMed ID: 28418444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline TP53 and MSH6 mutations implicated in sporadic triple-negative breast cancer (TNBC): a preliminary study.
    Yi D; Xu L; Luo J; You X; Huang T; Zi Y; Li X; Wang R; Zhong Z; Tang X; Li A; Shi Y; Rao J; Zhang Y; Sang J
    Hum Genomics; 2019 Jan; 13(1):4. PubMed ID: 30630526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and clinical implications of germline pathogenic variants in cancer predisposing genes in young patients across sarcoma subtypes.
    Carvalho NA; Santiago KM; Maia JML; Costa FD; Formiga MN; Soares DCQ; Paixão D; Mello CAL; Costa CMLD; Rocha JCCD; Rivera B; Carraro DM; Torrezan GT
    J Med Genet; 2023 Dec; 61(1):61-68. PubMed ID: 37536918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas.
    Pemov A; Li H; Patidar R; Hansen NF; Sindiri S; Hartley SW; Wei JS; Elkahloun A; Chandrasekharappa SC; ; Boland JF; Bass S; ; Mullikin JC; Khan J; Widemann BC; Wallace MR; Stewart DR
    Oncogene; 2017 Jun; 36(22):3168-3177. PubMed ID: 28068329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
    Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
    Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidating the molecular basis of MSH2-deficient tumors by combined germline and somatic analysis.
    Vargas-Parra GM; González-Acosta M; Thompson BA; Gómez C; Fernández A; Dámaso E; Pons T; Morak M; Del Valle J; Iglesias S; Velasco À; Solanes A; Sanjuan X; Padilla N; de la Cruz X; Valencia A; Holinski-Feder E; Brunet J; Feliubadaló L; Lázaro C; Navarro M; Pineda M; Capellá G
    Int J Cancer; 2017 Oct; 141(7):1365-1380. PubMed ID: 28577310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Contribution of Whole Gene Deletions and Large Rearrangements to the Mutation Spectrum in Inherited Tumor Predisposing Syndromes.
    Smith MJ; Urquhart JE; Harkness EF; Miles EK; Bowers NL; Byers HJ; Bulman M; Gokhale C; Wallace AJ; Newman WG; Evans DG
    Hum Mutat; 2016 Mar; 37(3):250-6. PubMed ID: 26615784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in the Childhood Cancer Survivor Study.
    Kim J; Gianferante M; Karyadi DM; Hartley SW; Frone MN; Luo W; Robison LL; Armstrong GT; Bhatia S; Dean M; Yeager M; Zhu B; Song L; Sampson JN; Yasui Y; Leisenring WM; Brodie SA; de Andrade KC; Fortes FP; Goldstein AM; Khincha PP; Machiela MJ; McMaster ML; Nickerson ML; Oba L; Pemov A; Pinheiro M; Rotunno M; Santiago K; Wegman-Ostrosky T; Diver WR; Teras L; Freedman ND; Hicks BD; Zhu B; Wang M; Jones K; Hutchinson AA; Dagnall C; Savage SA; Tucker MA; Chanock SJ; Morton LM; Stewart DR; Mirabello L
    JNCI Cancer Spectr; 2021 Apr; 5(2):. PubMed ID: 34308104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A germline missense mutation in exon 3 of the MSH2 gene in a Lynch syndrome family: correlation with phenotype and localization assay.
    Bianchi F; Maccaroni E; Belvederesi L; Brugiati C; Giampieri R; Bini F; Bracci R; Pagliaretta S; Del Prete M; Piva F; Mandolesi A; Scarpelli M; Berardi R
    Fam Cancer; 2018 Apr; 17(2):215-224. PubMed ID: 28785832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline and somatic NF1 gene mutations in plexiform neurofibromas.
    Upadhyaya M; Spurlock G; Monem B; Thomas N; Friedrich RE; Kluwe L; Mautner V
    Hum Mutat; 2008 Aug; 29(8):E103-11. PubMed ID: 18484666
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Oppel F; Ki DH; Zimmerman MW; Ross KN; Tao T; Shi H; He S; Aster JC; Look AT
    Dis Model Mech; 2020 Aug; 13(8):. PubMed ID: 32651197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF1-Related MicroRNA Gene Polymorphisms and the Susceptibility to Soft Tissue Sarcomas: A Case-Control Study.
    Zhang P; Huang L; Li X; Hu F; Niu X; Sun Y; Yao W; Tian W
    DNA Cell Biol; 2023 May; 42(5):229-238. PubMed ID: 36989515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive NF1 screening on cultured Schwann cells from neurofibromas.
    Maertens O; Brems H; Vandesompele J; De Raedt T; Heyns I; Rosenbaum T; De Schepper S; De Paepe A; Mortier G; Janssens S; Speleman F; Legius E; Messiaen L
    Hum Mutat; 2006 Oct; 27(10):1030-40. PubMed ID: 16941471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic susceptibility in children, adolescents, and young adults diagnosed with soft-tissue sarcomas.
    Würtemberger J; Ripperger T; Vokuhl C; Bauer S; Teichert-von Lüttichau I; Wardelmann E; Niemeyer CM; Kratz CP; Schlegelberger B; Hettmer S
    Eur J Med Genet; 2023 May; 66(5):104718. PubMed ID: 36764384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs).
    Upadhyaya M; Kluwe L; Spurlock G; Monem B; Majounie E; Mantripragada K; Ruggieri M; Chuzhanova N; Evans DG; Ferner R; Thomas N; Guha A; Mautner V
    Hum Mutat; 2008 Jan; 29(1):74-82. PubMed ID: 17960768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF1 and PTEN gene polymorphisms and the susceptibility to soft tissue sarcomas in a Chinese population: A case-control study.
    Zhang P; Liu J; Li X; Gao M; Feng F; Wang W; Zhang Q; Yao W
    Exp Mol Pathol; 2021 Feb; 118():104603. PubMed ID: 33422488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of MSH2 and MSH6 due to heterozygous germline defects in MSH3 and MSH6.
    Morak M; Käsbauer S; Kerscher M; Laner A; Nissen AM; Benet-Pagès A; Schackert HK; Keller G; Massdorf T; Holinski-Feder E
    Fam Cancer; 2017 Oct; 16(4):491-500. PubMed ID: 28528517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case report of a man with multiple paragangliomas and pathogenic germline variants in both NF1 and SDHD.
    Chatzikyriakou P; Touska P; Moonim MT; Obholzer R; Afridi S; Sandison A; Oakey RJ; Izatt L
    Cancer Genet; 2021 Aug; 256-257():110-114. PubMed ID: 34107390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.